Cancer Testing - G2 Intelligence

Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males

More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?

Start a Free Trial for immediate access to this article

Already a member? Log in here

G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.

Start a Free Trial for immediate access to this article

Already a member? Log in here

First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.

Start a Free Trial for immediate access to this article

Already a member? Log in here

A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.

Start a Free Trial for immediate access to this article

Already a member? Log in here